Trevi Therapeutics, Inc. (TRVI): Shares Outstanding

Annual figures by period end, from SEC filings.

128.31M
As of 2025-12-31
142.42M
As of 2026-06-30
+28.9%
3-year compound annual growth
2018-12-31: 438.6K2019-12-31: 17.83M2020-12-31: 18.55M2021-12-31: 28.51M2022-12-31: 59.94M2023-12-31: 68.28M2024-12-31: 93.60M2025-12-31: 128.31M128.31M
2018-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31128.31M+37.1%2026-03-17, Balance as of period end
2024-12-3193.60M+37.1%2026-03-17, Balance as of period end
2023-12-3168.28M+13.9%2025-03-18, Balance as of period end
2022-12-3159.94M+110.3%2024-03-20, Balance as of period end
2021-12-3128.51Mn/c2023-03-16, Balance as of period end
2020-12-3118.55M+4.0%2022-03-17, Balance as of period end
2019-12-3117.83Mn/m2021-03-25, Balance as of period end
2018-12-31438.6Kn/a2020-03-16, Balance as of period end